Hua Medicine (Shanghai) Ltd.
HUMDF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | $2,926,919 | $1,075,278 | $1,445,486 | $3,130,269 |
| - Cash | $1,022,788 | $1,139,753 | $1,338,809 | $1,460,824 |
| + Debt | $271,052 | $300,179 | $272,414 | $167,754 |
| Enterprise Value | $2,175,183 | $235,704 | $379,091 | $1,837,199 |
| Revenue | $217,432 | $153,229 | $102,663 | $6,279 |
| % Growth | 41.9% | 49.3% | 1,535% | – |
| Gross Profit | $117,819 | $76,962 | $47,762 | -$6,673 |
| % Margin | 54.2% | 50.2% | 46.5% | -106.3% |
| EBITDA | -$58,005 | -$159,286 | -$186,699 | -$196,242 |
| % Margin | -26.7% | -104% | -181.9% | -3,125.4% |
| Net Income | $1,183,946 | -$107,903 | -$142,241 | -$121,138 |
| % Margin | 544.5% | -70.4% | -138.6% | -1,929.3% |
| EPS Diluted | 1.2 | -0.11 | -0.145 | -0.124 |
| % Growth | 1,192.9% | 24.3% | -17.3% | – |
| Operating Cash Flow | -$84,414 | -$191,192 | -$226,774 | $630,598 |
| Capital Expenditures | $0 | -$1,868 | -$962 | -$2,676 |
| Free Cash Flow | -$84,414 | -$193,060 | -$227,736 | $627,922 |